ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Episode 423: ASCO 2025 - Casdatifan plus Cabo in refractory RCC

01/06/2025 30 min

Listen "Episode 423: ASCO 2025 - Casdatifan plus Cabo in refractory RCC"

Descargar episodio Ver en sitio original

Episode Synopsis

Toni Choueiri discusses this combination cohort of HIF inhibition plus VEGF-R inhibition.

More episodes of the podcast The Uromigos

Episode 470: Bladder Cancer Year in Review 29/12/2025

Episode 469: Prostate Cancer year in Review 22/12/2025

Episode 468: RCC Year in Review 15/12/2025

Episode 442: The History of ARPI Development in Prostate Cancer 24/11/2025

Episode 466: #UromigosLive 2025 - Novel Therapy in mRCC 10/11/2025

Episode 465: #UromigosLive 2025 - Adjuvant Therapy in RCC 10/11/2025

Episode 464: #UromigosLive 2025 - The Evolving Landscape of mHSPC 10/11/2025

Episode 459: #UromigosLive 2025 - Radioligands in Prostate Cancer 08/11/2025

Episode 458: #UromigosLive 2025 - Mock ODAC 08/11/2025

Episode 463: #UromigosLive 2025 Tres Uramigas: Resumen de la sesión sobre cáncer de vejiga metastásico 08/11/2025

Ver todos los episodios